CORE MOLDING TECHNOLOGIES IN (CMT)

US2186831002 - Common Stock

17.96  +0.03 (+0.17%)

After market: 17.96 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CMT. CMT was compared to 84 industry peers in the Chemicals industry. CMT gets an excellent profitability rating and is at the same time showing great financial health properties. CMT is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, CMT could be worth investigating further for value investing!.



8

1. Profitability

1.1 Basic Checks

CMT had positive earnings in the past year.
CMT had a positive operating cash flow in the past year.
CMT had positive earnings in 4 of the past 5 years.
CMT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CMT has a Return On Assets of 12.20%. This is amongst the best in the industry. CMT outperforms 95.24% of its industry peers.
CMT has a better Return On Equity (18.74%) than 86.90% of its industry peers.
CMT has a Return On Invested Capital of 16.83%. This is amongst the best in the industry. CMT outperforms 96.43% of its industry peers.
CMT had an Average Return On Invested Capital over the past 3 years of 9.70%. This is above the industry average of 7.41%.
The 3 year average ROIC (9.70%) for CMT is below the current ROIC(16.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.2%
ROE 18.74%
ROIC 16.83%
ROA(3y)5.97%
ROA(5y)2.82%
ROE(3y)9.79%
ROE(5y)3.91%
ROIC(3y)9.7%
ROIC(5y)N/A

1.3 Margins

CMT's Profit Margin of 5.70% is fine compared to the rest of the industry. CMT outperforms 65.48% of its industry peers.
In the last couple of years the Profit Margin of CMT has grown nicely.
CMT's Operating Margin of 7.57% is in line compared to the rest of the industry. CMT outperforms 41.67% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
With a Gross Margin value of 17.99%, CMT is not doing good in the industry: 65.48% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CMT has grown nicely.
Industry RankSector Rank
OM 7.57%
PM (TTM) 5.7%
GM 17.99%
OM growth 3Y17.04%
OM growth 5Y54.71%
PM growth 3Y17.58%
PM growth 5YN/A
GM growth 3Y5.17%
GM growth 5Y12.36%

7

2. Health

2.1 Basic Checks

CMT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CMT has more shares outstanding than it did 1 year ago.
CMT has more shares outstanding than it did 5 years ago.
CMT has a better debt/assets ratio than last year.

2.2 Solvency

CMT has an Altman-Z score of 5.12. This indicates that CMT is financially healthy and has little risk of bankruptcy at the moment.
CMT's Altman-Z score of 5.12 is amongst the best of the industry. CMT outperforms 92.86% of its industry peers.
The Debt to FCF ratio of CMT is 0.89, which is an excellent value as it means it would take CMT, only 0.89 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.89, CMT belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that CMT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, CMT is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.89
Altman-Z 5.12
ROIC/WACC1.96
WACC8.6%

2.3 Liquidity

A Current Ratio of 2.23 indicates that CMT has no problem at all paying its short term obligations.
CMT's Current ratio of 2.23 is in line compared to the rest of the industry. CMT outperforms 55.95% of its industry peers.
A Quick Ratio of 1.75 indicates that CMT should not have too much problems paying its short term obligations.
CMT has a better Quick ratio (1.75) than 70.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.75

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.07% over the past year.
CMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.26% yearly.
Looking at the last year, CMT shows a decrease in Revenue. The Revenue has decreased by -2.29% in the last year.
Measured over the past years, CMT shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)62.07%
EPS 3Y33.26%
EPS 5YN/A
EPS growth Q2Q-56.14%
Revenue 1Y (TTM)-2.29%
Revenue growth 3Y17.18%
Revenue growth 5Y5.83%
Revenue growth Q2Q-14.65%

3.2 Future

Based on estimates for the next years, CMT will show a decrease in Earnings Per Share. The EPS will decrease by -1.88% on average per year.
Based on estimates for the next years, CMT will show a small growth in Revenue. The Revenue will grow by 0.25% on average per year.
EPS Next Y-34.67%
EPS Next 2Y-1.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.6%
Revenue Next 2Y0.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.64, the valuation of CMT can be described as very cheap.
Based on the Price/Earnings ratio, CMT is valued cheaper than 90.48% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.06. CMT is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 11.70, the valuation of CMT can be described as reasonable.
Based on the Price/Forward Earnings ratio, CMT is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
CMT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.64
Fwd PE 11.7

4.2 Price Multiples

95.24% of the companies in the same industry are more expensive than CMT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CMT is valued cheaper than 94.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.38
EV/EBITDA 3.43

4.3 Compensation for Growth

The excellent profitability rating of CMT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (5/2/2024, 7:04:03 PM)

After market: 17.96 0 (0%)

17.96

+0.03 (+0.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap164.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.64
Fwd PE 11.7
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.2%
ROE 18.74%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.57%
PM (TTM) 5.7%
GM 17.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.23
Quick Ratio 1.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)62.07%
EPS 3Y33.26%
EPS 5Y
EPS growth Q2Q
EPS Next Y-34.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.29%
Revenue growth 3Y17.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y